CYP2E1 has been related to metabolic diseases; its activity has been shown to be increased in patients with T2DM and obesity [16,17] and several polymorphisms have been significantly associated with the risk of T2DM [18]. The gene discussed is CYP2E1; the disease is obesity due to melanocortin 4 receptor deficiency.